ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
DealStreetAsia

Indonesia's Halodoc closes drug delivery unit as COVID bites

Telemedicine startup ties up with insurers to get corporate deals

Halodoc CEO and co-founder Jonathan Sudharta said the company closed its drug delivery unit as orders fell during the pandemic. (Photo by Yuki Kohara) 

JAKARTA -- Halodoc, an Indonesian health-tech platform, was forced to shut down one of its business units that had been hit by the COVID-19 pandemic, a top company executive told DealStreetAsia.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more